CorMedix Inc
F:19KA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CorMedix Inc
F:19KA
|
US |
|
T
|
Targa Resources Corp
F:TAR
|
US |
|
AltC Acquisition Corp
NYSE:OKLO
|
US |
|
CareTrust REIT Inc
F:7XC
|
US |
|
M
|
MGIC Investment Corp
XMUN:MGC
|
US |
Wall St Price Targets
19KA Price Targets Summary
CorMedix Inc
According to Wall Street analysts, the average 1-year price target for 19KA is 17.923 EUR with a low forecast of 14.981 EUR and a high forecast of 22.763 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 19KA's stock price target?
Price Target
17.923
EUR
According to Wall Street analysts, the average 1-year price target for 19KA is 17.923 EUR with a low forecast of 14.981 EUR and a high forecast of 22.763 EUR.
What is the Revenue forecast for CorMedix Inc?
Projected CAGR
8%
The compound annual growth rate for Revenue over the next 8 years is 8%.
What is the Gross Profit forecast for CorMedix Inc?
Projected CAGR
8%
The compound annual growth rate for Gross Profit over the next 5 years is 8%.
What is the Operating Income forecast for CorMedix Inc?
Projected CAGR
6%
The compound annual growth rate for Operating Income over the next 8 years is 6%.
What is the Pre-Tax Income forecast for CorMedix Inc?
Projected CAGR
-28%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -28%.
What is the Net Income forecast for CorMedix Inc?
Projected CAGR
-36%
The compound annual growth rate for Net Income over the next 3 years is -36%.
